Cargando…
L‐asparaginase doses number as a prognostic factor in childhood acute lymphoblastic leukemia: A survival analysis study
BACKGROUND: The survival of children with acute lymphoblastic leukemia (ALL) has improved due to changes in the treatment and the disease diagnosis. A significant advance was the incorporation of asparaginase. However, hypersensitivity reactions are a common cause of early discontinuation of this dr...
Autores principales: | dos Santos, Amanda Cabral, dos Santos, Julia Maria Bispo, da Costa Lima, Elisangela, Land, Marcelo Gerardin Poirot |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351670/ https://www.ncbi.nlm.nih.gov/pubmed/34431241 http://dx.doi.org/10.1002/cnr2.1533 |
Ejemplares similares
-
Reactions related to asparaginase infusion in a 10-year retrospective cohort
por: Santos, Amanda Cabral dos, et al.
Publicado: (2017) -
Cathepsin B Is Not an Intrinsic Factor Related to Asparaginase Resistance of the Acute Lymphoblastic Leukemia REH Cell Line
por: Costa, Iris Munhoz, et al.
Publicado: (2023) -
Pharmacogenetics of asparaginase in acute lymphoblastic leukemia
por: Abaji, Rachid, et al.
Publicado: (2019) -
Intrachromosomal amplification of chromosome 21 (iAMP21) detected by
ETV6/RUNX1 FISH screening in childhood acute lymphoblastic leukemia: a case
report
por: Garcia, Daniela Ribeiro Ney, et al.
Publicado: (2013) -
Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
por: Maese, Luke, et al.
Publicado: (2022)